Total Funding
68
80
Total FundingPrivate Equity raised
Growth Score 68 in past quarter
-25 pts
Heat Score 80 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49906
QuadMedicine specializes in the design and development of microneedles for pharmaceuticals and medical devices.
- Seung-Ki Baek: Founder and CEO
- Jung-Hwan Park: CTO
About the Company
QuadMedicine is a biotech company focused on microneedle array patch (MAP) technology for transdermal drug and vaccine delivery. The company develops painless “patch-based injections” aimed at improving vaccine accessibility and stability, especially in remote or low-resource settings. The company has worked on vaccine patches targeting diseases
such as measles, polio, hepatitis B, and typhoid.